USA: +1 312-376-8303
EU: +44 208-144-9523
info@cognitivemarketresearch.com
D&B D-U-N-S No : 85-356-3074
Global Drug Repurposing Market Report 2025

Global Drug Repurposing
Market Report
2025

Home
Pharma & Healthcare
Drug Repurposing Market

Drug Repurposing Market Report 2025 (Global Edition)

The global Drug Repurposing Market size will be USD 759.2 million in 2025. The growing need for cost-effective treatments and faster drug development processes is expected to boost sales to USD 2421.134254 million by 2033, with a Compound Annual Growth Rate (CAGR) of 15.60% from 2025 to 2033.

Author Name: Manjiri Kanhere | Report ID: CMR142834  | 

The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.

Data Updated: April 2025  | Report Pages: 250+  | Edition: 8th  | 

PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.

Format: PDF, PPT, Excel, Word, Bi and Consultation  | 
Rating: 4.8 | Review: 10
Trump's Tariff War: Published/Updated report edition outlines impact of Trump’s Tariff War on Drug Repurposing market and provides more insights.

Share your contact details to receive free updated sample copy/pages of the recently published edition of Drug Repurposing Market Report 2025.

Global Drug Repurposing Market Report 2025 Market Size Split by By Approach Type Outlook: (Disease-centric approach, Target-centric approach, Drug-centric approach), by By Disease Indication Outlook: ...

According to Cognitive Market Research, the global Drug Repurposing Market size will be USD 759.2 million in 2025. It will expand at a compound annual growth rate (CAGR) of 15.60% from 2025 to 2033.

  • North America held the major market share for more than 37% of the global revenue with a market size of USD 280.90 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2025 to 2033.
  • Europe accounted for a market share of over 29% of the global revenue with a market size of USD 220.17 million.
  • APAC held a market share of around 24% of the global revenue with a market size of USD 182.21 million in 2025 and will grow at a compound annual growth rate (CAGR) of 17.6% from 2025 to 2033.
  • South America has a market share of more than 3.8% of the global revenue with a market size of USD 28.85 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2025 to 2033.
  • Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 30.37 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2025 to 2033.
  • Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 16.70 million in 2025. It will grow at a compound annual growth rate (CAGR) of 15.3% from 2025 to 2033.
  • Oncology therapeutic area is the fastest growing segment of the Drug Repurposing industry

 

Preview of Global Drug Repurposing Market Revenue

Drug Repurposing Market Size, CAGR and Industry Statistics
202120252033CAGR
Global Drug Repurposing Market Sales Revenue121212121212$ 2421.13 Million15.6%
North America Drug Repurposing Market Sales Revenue121212$ 280.9 Million$ 768.2 Million13.4%
United States Drug Repurposing Market Sales Revenue121212$ 221.63 Million12121213.2%
Canada Drug Repurposing Market Sales Revenue121212$ 33.71 Million12121214.2%
Mexico Drug Repurposing Market Sales Revenue121212$ 25.56 Million12121213.9%
Europe Drug Repurposing Market Sales Revenue121212$ 220.17 Million$ 623.7 Million13.9%
United Kingdom Drug Repurposing Market Sales Revenue121212$ 36.99 Million12121214.7%
France Drug Repurposing Market Sales Revenue121212$ 20.26 Million12121213.1%
Germany Drug Repurposing Market Sales Revenue121212$ 43.59 Million12121214.1%
Italy Drug Repurposing Market Sales Revenue121212$ 18.93 Million12121213.3%
Russia Drug Repurposing Market Sales Revenue121212$ 34.13 Million12121212.9%
Spain Drug Repurposing Market Sales Revenue121212$ 18.05 Million12121213%
Sweden Drug Repurposing Market Sales Revenue121212$ 6.83 Million12121214%
Denmark Drug Repurposing Market Sales Revenue121212$ 4.62 Million12121213.7%
Switzerland Drug Repurposing Market Sales Revenue121212$ 3.3 Million12121213.6%
Luxembourg Drug Repurposing Market Sales Revenue121212$ 2.64 Million12121214.2%
Rest of Europe Drug Repurposing Market Sales Revenue121212$ 30.82 Million12121213.2%
Asia Pacific Drug Repurposing Market Sales Revenue121212$ 182.21 Million$ 666.5 Million17.6%
China Drug Repurposing Market Sales Revenue121212$ 76.53 Million12121217.1%
Japan Drug Repurposing Market Sales Revenue121212$ 25.14 Million12121216.1%
South Korea Drug Repurposing Market Sales Revenue121212$ 21.86 Million12121216.7%
India Drug Repurposing Market Sales Revenue121212$ 18.22 Million12121219.5%
Australia Drug Repurposing Market Sales Revenue121212$ 9.47 Million12121216.9%
Singapore Drug Repurposing Market Sales Revenue121212$ 3.64 Million12121217.9%
Taiwan Drug Repurposing Market Sales Revenue121212$ 7.11 Million12121217.4%
South East Asia Drug Repurposing Market Sales Revenue121212$ 12.03 Million12121218.4%
Rest of APAC Drug Repurposing Market Sales Revenue121212$ 8.2 Million12121217.4%
South America Drug Repurposing Market Sales Revenue121212$ 28.85 Million$ 85.8 Million14.6%
Brazil Drug Repurposing Market Sales Revenue121212$ 12.35 Million12121215.2%
Argentina Drug Repurposing Market Sales Revenue121212$ 4.85 Million12121215.5%
Colombia Drug Repurposing Market Sales Revenue121212$ 2.57 Million12121214.4%
Peru Drug Repurposing Market Sales Revenue121212$ 2.37 Million12121214.8%
Chile Drug Repurposing Market Sales Revenue121212$ 2.08 Million12121214.9%
Rest of South America Drug Repurposing Market Sales Revenue121212$ 4.64 Million12121213.7%
Middle East Drug Repurposing Market Sales Revenue121212$ 30.37 Million$ 92.3 Million14.9%
Qatar Drug Repurposing Market Sales Revenue121212$ 2.43 Million12121214.2%
Saudi Arabia Drug Repurposing Market Sales Revenue121212$ 10.69 Million12121215.2%
Turkey Drug Repurposing Market Sales Revenue121212$ 2.43 Million12121215.5%
UAE Drug Repurposing Market Sales Revenue121212$ 6.26 Million12121215.4%
Egypt Drug Repurposing Market Sales Revenue121212$ 1.82 Million12121214.7%
Rest of Middle East Drug Repurposing Market Sales Revenue121212$ 6.74 Million12121214.1%
Africa Drug Repurposing Market Sales Revenue121212$ 16.7 Million$ 52.2 Million15.3%
Nigeria Drug Repurposing Market Sales Revenue121212$ 1.34 Million12121215.5%
South Africa Drug Repurposing Market Sales Revenue121212$ 5.88 Million12121216.2%
Rest of Africa Drug Repurposing Market Sales Revenue121212$ 9.49 Million12121214.5%
Base Year2024
Historical Data Time Period2021-2024
Forecast Period2025-2033
Market Split by By Approach Type Outlook:
  • Disease-centric approach
  • Target-centric approach
  • Drug-centric approach
Market Split by By Disease Indication Outlook:
  • Oncology
  • CNS Diseases
  • Neurodegenerative Diseases
  • Others (Rare Disorders
  • etc.)
Market Split by By End-user Outlook:
  • Hospitals & Clinics
  • Ambulatory Surgery Diseases
  • Others (Research Institutes
  • etc.)
List of Competitors
  • Algernon Pharmaceuticals
  • Biovista Inc.
  • Celentyx Ltd.
  • ChemBio Discovery Inc.
  • Chord Therapeutics SA
  • Excelra
  • Fios Genomics Ltd.
  • Lantern Pharma Inc.
  • Novartis AG
  • Paradigm Biopharmaceuticals Limited
  • Predictive Oncology
  • Segue Therapeutics
  • LLC
  • Teva Pharmaceutical Industries Ltd.
  • Confidential Data
  • Access The Paid Version
  • Data Hidden
Regional Analysis
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
Country Analysis
  • North America (United States, Canada, Mexico)
  • Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
  • Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
  • Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
  • Africa (Nigeria, South Africa, Rest of Africa)
Market Drivers:
  • High cost and time of traditional drug development drive interest in faster, cost-effective alternatives like repurposing
  • Rising prevalence of chronic and rare diseases increases demand for new therapeutic options
  • Regulatory support and incentives encourage companies to explore repurposing of existing drugs
Market Restrains:
  • Patent and intellectual property challenges limit commercial incentives for repurposed drugs
  • Limited clinical data for new indications can hinder regulatory approvals and market adoption
Market Trends:
  • Increased collaboration between pharma companies and research institutes
  • Growing use of AI and big data in identifying new drug indications

Report scope is customizable as we have a huge database of Drug Repurposing industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Drug Repurposing Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!

Drug Repurposing Market Report Description

Introduction of the Drug Repurposing Market

The drug repurposing Market involves exploring existing drugs for new therapeutic indications, offering a faster, cost-effective alternative to traditional drug development. This Market is driven by the need for more efficient treatments for chronic, rare, and complex diseases. It benefits from advancements in AI, biotechnology, and growing collaboration between pharmaceutical companies and research institutions. The Market is expanding rapidly, with increasing investments in repurposing efforts due to the lower cost, reduced development time, and the potential to address unmet medical needs. This growth is expected to continue as technology evolves.

In May 2025, Algernon is set to acquire NoBrainer Imaging Centers, Inc. as part of its strategic move to establish specialized Alzheimer’s diagnostic and treatment medical clinics. These clinics will feature cutting-edge PET scan technology aimed at enhancing early detection and treatment of Alzheimer’s disease. The acquisition reflects Algernon’s commitment to advancing medical solutions in neurology. By integrating innovative imaging technology, the company aims to improve patient outcomes and drive progress in Alzheimer’s care. ”https://www.algernonpharmaceuticals.com/news-media/news-releases/detail/218/algernon-to-acquire-nobrainer-imaging-centers-inc---plans”

Drug Repurposing Market Size

Market Dynamics of Drug Repurposing Market

Key Drivers for Drug Repurposing Market

Harnessing the Power of Artificial Intelligence to Accelerate Drug Repurposing and Transform Pharmaceutical Innovation

The use of Artificial Intelligence (AI) in drug repurposing is transforming pharmaceutical research by discovering new uses for existing drugs faster and more precise. AI can process and analyze massive datasets—such as genetic, clinical, and chemical data—to identify promising drug-disease matches. This drastically cuts down the time and cost of drug development, which traditionally takes many years and requires significant investment. As AI continues to gain traction, its growing role in drug discovery reflects the industry's recognition of its ability to streamline processes and improve research outcomes?. In February 2025, Artificial intelligence is reshaping drug discovery by significantly improving speed, efficiency, and precision. By leveraging AI tools, researchers can better identify promising drug-target interactions, repurpose existing compounds, and streamline the clinical trial process. This technological shift allows pharmaceutical companies to bring targeted treatments to market faster and at lower costs.

”https://pharma.economictimes.indiatimes.com/news/pharma-industry/ai-revolutionising-drug-discovery/117916035?utm_”

Rising Demand for Effective Treatments for Rare and Chronic Diseases

The increasing prevalence of rare and chronic diseases is driving significant growth in the drug repurposing market. As these conditions often have limited treatment options, pharmaceutical companies are exploring existing drugs for new indications. Repurposing allows for quicker, cost-effective solutions compared to developing new drugs. The demand for effective therapies for these diseases continues to rise, prompting more investments and collaborations focused on repurposing existing drugs. This shift is expected to accelerate as companies seek to address unmet medical needs and improve patient outcomes.

Restraint Factor for the Drug Repurposing Market

Intellectual Property and Patent Issues as Key Challenges in Drug Repurposing Development

Intellectual property (IP) and patent issues pose significant challenges to drug repurposing. Existing drugs are often protected by patents, making it difficult for companies to explore new therapeutic uses. The complexity of patent laws, including variations across regions, can create barriers to repurposing, especially when patents remain active in certain markets. This can lead to disputes and delays in development, limiting the commercial incentives for repurposing drugs. These IP challenges hinder the growth of the drug repurposing market by complicating the legal and financial aspects of the process.

We have various report editions of Drug Repurposing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Trump Tariffs on the Drug Repurposing Market

Trump's tariffs on pharmaceutical imports raise the cost of essential raw materials and APIs, which are crucial for manufacturing drugs. These higher costs can make it more expensive for companies to develop and produce repurposed drugs, slowing down progress in the drug repurposing market.

The tariffs disrupt established global supply chains, affecting the timely delivery of materials and finished products. For drug repurposing efforts, delays in the availability of necessary ingredients can hinder clinical trials and development timelines.

With tariffs increasing the cost of imported medicines and components, pharmaceutical companies may pass these higher costs onto consumers. This could make repurposed drugs more expensive for patients, limiting access to affordable treatment options and affecting market demand.?

Many repurposed drugs are generic versions of established treatments, which are heavily dependent on affordable imported APIs. Tariffs can increase production costs for generic drugs, potentially leading to higher prices or reduced availability, ultimately limiting the effectiveness of repurposing strategies.

Competitive Landscape of the Drug Repurposing Market

The competitive landscape of the drug repurposing market is evolving rapidly, with key players focusing on leveraging AI, machine learning, and advanced analytics to accelerate the identification of new drug indications. Major pharmaceutical companies, along with biotech startups, are intensifying efforts to repurpose existing drugs for complex diseases, aiming to reduce development costs and timelines. Collaborations and strategic partnerships are also increasing as companies seek to enhance their research capabilities and market reach. This dynamic environment is fostering innovation and driving competition among industry leaders.

In June 2024, Excelra and AsedaSciences entered into a strategic co-marketing agreement to offer scientists a unified, user-friendly platform for small molecule toxicity assessment. This collaboration aims to streamline the evaluation process, providing researchers with an efficient tool for assessing drug safety. By combining their expertise, both companies seek to enhance the capabilities available to scientists in the field of toxicity research. The partnership will enable more accessible and effective solutions for assessing the safety of small molecules. ”https://www.excelra.com/news/asedasciences-partners-with-excelra-for-gostar/" In April 2025, Novartis has reached an agreement to acquire Regulus Therapeutics, a San Diego-based clinical-stage biopharmaceutical company specializing in microRNA therapeutics. Regulus’ leading asset, faburden, targets miR-17 and shows potential as a first-in-class treatment for autosomal dominant polycystic kidney disease (ADPKD). This acquisition aligns with Novartis' focus on renal disease and will enhance its expertise in this therapeutic area. The deal strengthens Novartis' portfolio by incorporating innovative approaches to treating kidney diseases. ”https://www.novartis.com/news/media-releases/novartis-acquire-regulus-therapeutics-and-farabursen-investigational-microrna-inhibitor-treat-adpkd-most-common-genetic-cause-renal-failure"

Top Companies Market Share in Drug Repurposing Industry: (In no particular order of Rank)

  • Algernon Pharmaceuticals
  • Biovista Inc.
  • Celentyx Ltd.
  • ChemBio Discovery Inc.
  • Chord Therapeutics SA
  • Excelra
  • Fios Genomics Ltd.
  • Lantern Pharma Inc.
  • Novartis AG
  • Paradigm Biopharmaceuticals Limited
  • Predictive Oncology
  • Segue Therapeutics
  • LLC
  • Teva Pharmaceutical Industries Ltd.
  • Confidential Data
  • Access The Paid Version
  • Data Hidden
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Drug Repurposing Market

Which Region Dominates the Drug Repurposing Market in 2025?

According to Cognitive Market Research, North America dominates the drug repurposing Market due to its well-established healthcare infrastructure, significant investments in research and development, and the presence of leading pharmaceutical companies and academic institutions. The region benefits from advanced technological capabilities, particularly in AI and data analytics, which are crucial for accelerating drug repurposing efforts. Additionally, favourable regulatory frameworks and strong intellectual property protections encourage innovation. North America's large patient population and focus on addressing unmet medical needs further bolster its dominance in the Market.

Which Region is Expanding at the Fastest CAGR?

The Asia-Pacific region is the fastest-growing Market for drug repurposing, driven by rapid advancements in healthcare infrastructure and growing investment in biotechnology. Countries like China, India, and Japan are increasingly adopting AI and big data analytics to enhance drug discovery processes. The rising burden of chronic and rare diseases, combined with the need for cost-effective healthcare solutions, is accelerating the demand for repurposed drugs. Furthermore, governments in the region are introducing favourable policies and incentives, boosting the growth of the drug repurposing market in Asia-Pacific.

The current report Scope analyzes Drug Repurposing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

  • North America (United States, Canada, Mexico)
  • Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
  • Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
  • Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
  • Africa (Nigeria, South Africa, Rest of Africa)

Drug Repurposing Market Share (%) by Region (2021-2033)

Drug Repurposing Market Share (%) by Country

The above graph is for illustrative purposes only.

To learn more about geographical trends request the free sample pages.

Get Free Sample

North America Drug Repurposing Market Analysis

According to Cognitive Market Research, the global Drug Repurposing Market size was estimated at USD 759.2 Million, out of which North America held the major market share of more than 37% of the global revenue with a market size of USD 280.90 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2025 to 2033.

United State Drug Repurposing Market size is USD 221.63 million in 2025

According to Cognitive Market Research, the US had a major share in the Drug Repurposing Market with a market size of USD 221.63 million in 2025 and is projected to grow at a CAGR of 13.2% during the forecast period. US is dominant due to strong R&D infrastructure and major pharma presence.

Canada Drug Repurposing Market size is USD 33.71 million in 2025

The Canadian Drug Repurposing Market had a market share of USD 33.71 million in 2025 and is projected to grow at a CAGR of 14.2% during the forecast period. Canada is the fastest growing, driven by supportive regulations and rising biotech investments.

Mexico Drug Repurposing Market size is USD 25.56 million in 2025

The Mexico Drug Repurposing Market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 25.56 million in 2025..

Europe Drug Repurposing Market Analysis

According to Cognitive Market Research, The global Drug Repurposing Market size was estimated at USD 759.2 Million, out of which Europe held the market share of more than 29% of the global revenue with a market size of USD 220.17 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2033.

United Kingdom Drug Repurposing Market size is USD 36.99 million in 2025

The United Kingdom Drug Repurposing Market had a market share of USD 36.99 million in 2025 and is projected to grow at a CAGR of 14.7% during the forecast period. UK is the fastest growing due to increased funding and focus on rare disease repurposing.

France Drug Repurposing Market size is USD 20.26 million in 2025

The France Drug Repurposing Market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 20.26 million in 2025.

Germany Drug Repurposing Market size is USD 43.59 million in 2025

According to Cognitive Market Research, the German Drug Repurposing Market size was valued at USD 43.59 million in 2025 and is projected to grow at a CAGR of 14.1% during the forecast period. Germany is dominant with strong pharmaceutical manufacturing and research capabilities.

Italy Drug Repurposing Market size is USD 18.93 million in 2025

The Italy Drug Repurposing Market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 18.93 million in 2025.

Russia Drug Repurposing Market size is USD 34.13 million in 2025

The Russia Drug Repurposing Market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 34.13 million in 2025

Spain Drug Repurposing Market size is USD 18.05 million in 2025

The Spain Drug Repurposing Market is projected to witness growth at a CAGR of 13.0% during the forecast period with a market size of USD 18.05 million in 2025

Sweden Drug Repurposing Market size is USD 6.83 million in 2025

The Sweden Drug Repurposing Market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 6.83 million in 2025.

Denmark Drug Repurposing Market size is USD 4.62 million in 2025

The Denmark Drug Repurposing Market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 4.62 million in 2025

Switzerland Drug Repurposing Market size is USD 3.30 million in 2025

The Switzerland Drug Repurposing Market is projected to witness growth at a CAGR of 13.6% during the forecast period, with a market size of USD 3.30 million in 2025.

Luxembourg Drug Repurposing Market size is 2.64 million in 2025

The Luxembourg Drug Repurposing Market is projected to witness growth at a CAGR of 14.2% during the forecast period, with a market size of USD 2.64 million in 2025.

Rest of Europe Drug Repurposing Market size is USD 30.82 million in 2025

The Rest of Europe's Drug Repurposing Market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 30.82 million in 2025.

Asia Pacific Drug Repurposing Market Analysis

According to Cognitive Market Research, the global Drug Repurposing Market size was estimated at USD 759.2 Million, out of which APAC held the market share of around 24% of the global revenue with a market size of USD 182.21 million in 2025 and will grow at a compound annual growth rate (CAGR) of 17.6% from 2025 to 2033.

China Drug Repurposing Market size is USD 76.53 million in 2025

The China Drug Repurposing Market size was valued at USD 76.53 million in 2025 and is projected to grow at a CAGR of 17.1% during the forecast period. China is dominant in the drug repurposing Market with strong government backing and clinical research infrastructure.

Japan Drug Repurposing Market size is USD 25.14 million in 2025

The Japan Drug Repurposing Market is projected to witness growth at a CAGR of 16.1% during the forecast period, with a market size of USD 25.14 million in 2025

South Korea Drug Repurposing Market size is USD 21.86 million in 2025

The South Korea Drug Repurposing Market had a market share of USD 21.86 million in 2025 and is projected to grow at a CAGR of 16.7% during the forecast period.

India Drug Repurposing Market size is USD 18.22 million in 2025

The Indian Drug Repurposing Market is projected to witness growth at a CAGR of 19.5% during the forecast period, with a market size of USD 18.22 million in 2025. India is the fastest growing in the drug repurposing Market due to affordable R&D and expanding pharma capabilities.

Australia Drug Repurposing Market size is USD 9.47 million in 2025

The Australian Drug Repurposing Market is projected to witness growth at a CAGR of 16.9% during the forecast period, with a market size of USD 9.47 million in 2025.

Singapore Drug Repurposing Market size is USD 3.64 million in 2025

The Singapore Drug Repurposing Market is projected to witness growth at a CAGR of 17.9% during the forecast period, with a market size of USD 3.64 million in 2025.

Taiwan Drug Repurposing Market size is USD 7.11 million in 2025

The Taiwan Drug Repurposing Market is projected to witness growth at a CAGR of 17.4% during the forecast period, with a market size of USD 7.11 million in 2025.

South East Asia Drug Repurposing Market size is USD 12.03 million in 2025

The South East Asia Drug Repurposing Market is projected to witness growth at a CAGR of 18.4% during the forecast period, with a market size of USD 12.03 million in 2025.

Rest of APAC Drug Repurposing Market size is USD 8.20 million in 2025

The Rest of APAC Drug Repurposing Market is projected to witness growth at a CAGR of 17.4% during the forecast period, with a market size of USD 8.20 million in 2025.

South America Drug Repurposing Market Analysis

According to Cognitive Market Research, the global Drug Repurposing Market size was estimated at USD 759.2 Million, out of which South America held the market share of around 3.8% of the global revenue with a market size of USD 28.85 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2025 to 2033.

Brazil Drug Repurposing Market size is USD 12.35 million in 2025

The Brazil Drug Repurposing Market size was valued at USD 12.35 million in 2025 and is projected to grow at a CAGR of 15.2% during the forecast period. Brazil is dominant in the drug repurposing Market with a large healthcare infrastructure and research collaborations.

Argentina Drug Repurposing Market size is USD 4.85 million in 2025

Argentina's Drug Repurposing Market had a market share of USD 4.85 million in 2025 and is projected to grow at a CAGR of 15.5% during the forecast period. Argentina is the fastest growing in the drug repurposing Market due to increasing clinical trials and governmental support for innovation.

Colombia Drug Repurposing Market size is USD 2.57 million in 2025

Colombia Drug Repurposing Market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 2.57 million in 2025

Peru Drug Repurposing Market size is USD 2.37 million in 2025

Peru Drug Repurposing Market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 2.37 million in 2025.

Chile Drug Repurposing Market size is USD 2.08 million in 2025

Chile Drug Repurposing Market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 2.08 million in 2025

Rest of South America Drug Repurposing Market size is USD 4.64 million in 2025

The Rest of South America's Drug Repurposing Market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 4.64 million in 2025.

Middle East Drug Repurposing Market Analysis

According to Cognitive Market Research, the global Drug Repurposing Market size was estimated at USD 759.2 Million, out of which the Middle East held the major market share of around 4% of the global revenue with a market size of USD 30.37 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2025 to 2033.

Qatar Drug Repurposing Market size is USD 2.43 million in 2025

The Qatar Drug Repurposing Market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 2.43 million in 2025. Qatar leads in drug repurposing with strong healthcare infrastructure and demand for specialized treatments.

Saudi Arabia Drug Repurposing Market size is USD 10.69 million in 2025

The Saudi Arabia Drug Repurposing Market is projected to witness growth at a CAGR of 15.2% during the forecast period, with a market size of USD 10.69 million in 2025.

Turkey Drug Repurposing Market size is USD 2.43 million in 2025

The Turkey Drug Repurposing Market is projected to witness growth at a CAGR of 15.5% during the forecast period, with a market size of USD 2.43 million in 2025. Turkey is rapidly growing in drug repurposing due to rising R&D investments and government support.

UAE Drug Repurposing Market size is USD 6.26 million in 2025

The UAE Drug Repurposing Market is projected to witness growth at a CAGR of 15.4% during the forecast period, with a market size of USD 6.26 million in 2025.

Egypt Drug Repurposing Market size is USD 1.82 million in 2025

The Egypt Drug Repurposing Market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 1.82 million in 2025.

Rest of the Middle East Drug Repurposing Market size is USD 6.74 million in 2025

The Rest of the Middle East Drug Repurposing Market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 6.74 million in 2025.

Africa Drug Repurposing Market Analysis

According to Cognitive Market Research, the global Drug Repurposing Market size was estimated at USD 759.2 Million, out of which Africa held the major market share of around 2.20% of the global revenue with a market size of USD 16.70 million in 2025 and will grow at a compound annual growth rate (CAGR) of 15.3% from 2025 to 2033.

Nigeria Drug Repurposing Market size is USD 1.34 million in 2025

The Nigeria Drug Repurposing Market is projected to witness growth at a CAGR of 15.5% during the forecast period, with a market size of USD 1.34 million in 2025. Drug Repurposing Market sales flourish due to the adoption of 60 GHz frequency bands for consumer and enterprise use.

South Africa Drug Repurposing Market size is USD 5.88 million in 2025

The South Africa Drug Repurposing Market is projected to witness growth at a CAGR of 16.2% during the forecast period, with a market size of USD 5.88 million in 2025. South Africa is the fastest-growing country with strong local pharmaceutical R&D and industry expansion.

Rest of Africa Drug Repurposing Market size is USD 9.49 million in 2025

The Rest of Africa Drug Repurposing Market is projected to witness growth at a CAGR of 14.5% during the forecast period, with a market size of USD 9.49 million in 2025. Africa is dominant in drug repurposing due to global collaborations and focus on affordable treatments.

Drug Repurposing Market Analysis

Global Drug Repurposing Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Drug Repurposing Industry growth. Drug Repurposing market has been segmented with the help of its By Approach Type Outlook:, By Disease Indication Outlook: By End-user Outlook:, and others. Drug Repurposing market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

How are Segments Performing in the Global Drug Repurposing Market?

Drug Repurposing Market Approach Type Segment Analysis

According to Cognitive Market Research, the disease-centric approach is currently the dominant category in the drug repurposing market. This approach focuses on identifying new therapeutic uses for existing drugs based on specific diseases, especially those with unmet medical needs like cancer, neurological disorders, and rare diseases. By leveraging existing drugs to treat a range of diseases, this method allows for quicker, cost-effective treatments. Researchers can focus on diseases with high prevalence or complex pathologies, making the disease-centric approach highly effective for addressing significant health challenges and improving patient outcomes.

The target-centric approach is the fastest-growing segment in the drug repurposing market. This strategy involves focusing on specific biological targets, such as proteins or genes, and identifying existing drugs that may interact with these targets to treat various diseases. With the rise of precision medicine and advancements in biotechnology, the target-centric approach is gaining traction due to its ability to tailor treatments to individual molecular profiles. The increasing use of AI and machine learning to predict target-disease relationships further accelerates its growth, making it a key focus in modern drug repurposing efforts.

Drug Repurposing Market Share (%) by By Approach Type Outlook: in 2021-2033

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Drug Repurposing Industry. Request a Free Sample PDF!

Drug Repurposing Market Disease Indication Segment Analysis

According to Cognitive Market Research, Oncology is the dominant category in the drug repurposing market. Cancer remains one of the most significant global health challenges, driving substantial investments in drug development. Repurposing existing drugs for oncology-related indications allows for faster clinical development and potentially lower costs compared to traditional cancer drug discovery. Many existing medications, originally designed for other conditions, have shown promise in targeting cancer cells. This has led to the increasing adoption of the disease-centric approach in oncology, positioning it as the leading focus area in the drug repurposing market.

Neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s disease, represent the fastest-growing category in the drug repurposing market. The rising global prevalence of these diseases, coupled with limited treatment options, is driving interest in repurposing existing drugs. With the advancement of technologies like AI and biomarkers, researchers are uncovering potential repurposed treatments more quickly. Given the ageing global population and the complex nature of neurodegenerative diseases, this segment is experiencing rapid growth as the search for effective therapies intensifies.

Drug Repurposing Market Share (%) by By Disease Indication Outlook: in 2021-2033

2021

2025

2033

The above Graph is for representation purposes only. This chart does not depict actual Market share.

To learn more about market share request the free sample pages.

Get Free Sample

Drug Repurposing By End-user Outlook: Segment Analysis

Drug Repurposing Market End-user Segment Analysis

According to Cognitive Market Research, Hospitals and clinics are the dominant end-user category in the drug repurposing market. These healthcare settings are the primary locations where drug repurposing is implemented for patient care. Hospitals and clinics are where patients with a wide range of diseases, including chronic and rare conditions, receive treatment. The ability to quickly introduce repurposed drugs in these environments, especially for conditions like cancer or neurodegenerative diseases, makes hospitals and clinics a central focus for drug repurposing efforts. Their established infrastructure and patient base contribute to their dominance in the Market.

Ambulatory surgery centres (ASCs) are the fastest-growing end-user category in the drug repurposing market. These centres are becoming more prominent due to their ability to provide cost-effective outpatient procedures and treatments. ASCs are increasingly adopting repurposed drugs to manage conditions requiring surgical interventions, such as certain cancers and orthopaedic conditions. As the demand for more affordable and efficient healthcare grows, ambulatory surgery centres are rapidly expanding their role in administering repurposed drugs, making them a key growth driver in the drug repurposing market.

  • Hospitals & Clinics
  • Ambulatory Surgery Diseases
  • Others (Research Institutes
  • etc.)

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Bio :

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.

In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.

Read More


Author's Conclusion

Conclusion

  • The global Drug Repurposing Market will expand significantly by 15.60% CAGR between 2025 and 2033.
  • The Disease-centric approach is the dominant category in drug repurposing as it focuses on identifying treatments based on disease characteristics, allowing quicker application of existing drugs to conditions with unmet medical needs.
  • Oncology is the dominant disease indication in the drug repurposing Market due to the high global cancer burden and the urgent need for cost-effective, fast-track treatment options using existing drugs.

Frequently Asked Questions (FAQs)

What is the market size for the Drug Repurposing Market in 2025?
The global market size for the Drug Repurposing Market in 2025 is USD 759.2 million.
What is the growth rate for the Drug Repurposing Market over the forecast period?
The global Drug Repurposing Market is expected to grow with a CAGR of 15.60% over the projected period.
Which is the leading region of the Market for Drug Repurposing Market?
North America held a significant global Drug Repurposing Market revenue share in 2025.
Which region is projected to detect the fastest growth in the Drug Repurposing Market over the forecast period?
Asia-Pacific will witness the fastest growth of the global Drug Repurposing Market over the coming years.
Which country will be leading in the Drug Repurposing Market in 2025?
The US had the most significant global Drug Repurposing Market revenue share in 2025.
What are the key drivers for the growth of the Drug Repurposing Market?
Developing a new drug from scratch can take over a decade and cost billions. Repurposing existing drugs significantly shortens development time and reduces costs, driving market growth.
Which is the significant Drug Repurposing Market segment by End-user?
The Hospitals & Clinics category dominates the Market.

Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.

Latest News about Drug Repurposing Market

Sources from Pharma & Healthcare Industry

Drug Repurposing Market Report Table of Content

Disclaimer:

  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
By Approach Type Outlook: Disease-centric approach, Target-centric approach, Drug-centric approach
By Disease Indication Outlook: Oncology, CNS Diseases, Neurodegenerative Diseases, Others (Rare Disorders, etc.)
By End-user Outlook: Hospitals & Clinics, Ambulatory Surgery Diseases, Others (Research Institutes, etc.)
List of Competitors Algernon Pharmaceuticals, Biovista Inc., Celentyx Ltd., ChemBio Discovery Inc., Chord Therapeutics SA, Excelra, Fios Genomics Ltd., Lantern Pharma Inc., Novartis AG, Paradigm Biopharmaceuticals Limited, Predictive Oncology, Segue Therapeutics, LLC, Teva Pharmaceutical Industries Ltd.
Expand All

This chapter will help you gain GLOBAL Market Analysis of Drug Repurposing. Further deep in this chapter, you will be able to review Global Drug Repurposing Market Split by various segments and Geographical Split.

Chapter 1 Global Market Analysis
  • 1.1 Global Drug Repurposing Revenue Market Size, Trend Analysis 2021 - 2033

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    1.2 Global Drug Repurposing Market Size By Regions 2021 - 2033
    • 1.2.1 Global Drug Repurposing Revenue Market Size By Region
  • 1.3 Global Drug Repurposing Market Size By By Approach Type Outlook: 2021 - 2033
    • 1.3.1 Disease-centric approach Market Size
    • 1.3.2 Target-centric approach Market Size
    • 1.3.3 Drug-centric approach Market Size
  • 1.4 Global Drug Repurposing Market Size By By Disease Indication Outlook: 2021 - 2033
    • 1.4.1 Oncology Market Size
    • 1.4.2 CNS Diseases Market Size
    • 1.4.3 Neurodegenerative Diseases Market Size
    • 1.4.4 Others (Rare Disorders Market Size
    • 1.4.5 etc.) Market Size
  • 1.5 Global Drug Repurposing Market Size By By End-user Outlook: 2021 - 2033
    • 1.5.1 Hospitals & Clinics Market Size
    • 1.5.2 Ambulatory Surgery Diseases Market Size
    • 1.5.3 Others (Research Institutes Market Size
    • 1.5.4 etc.) Market Size
  • 1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    1.7 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 1.7.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 1.7.2 Global Market Revenue Split By By Approach Type Outlook:
    • 1.7.3 Global Market Revenue Split By By Disease Indication Outlook:
    • 1.7.4 Global Market Revenue Split By By End-user Outlook:

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
  • 2.1 North America Drug Repurposing Market Size 2021 - 2033
    • 2.1.1 North America Drug Repurposing Market Size By Country 2021 - 2033
    • 2.1.2 North America Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
      • 2.1.2.1 North America Disease-centric approach Market Size
      • 2.1.2.2 North America Target-centric approach Market Size
      • 2.1.2.3 North America Drug-centric approach Market Size
    • 2.1.3 North America Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
      • 2.1.3.1 North America Oncology Market Size
      • 2.1.3.2 North America CNS Diseases Market Size
      • 2.1.3.3 North America Neurodegenerative Diseases Market Size
      • 2.1.3.4 North America Others (Rare Disorders Market Size
      • 2.1.3.5 North America etc.) Market Size
    • 2.1.4 North America Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
      • 2.1.4.1 North America Hospitals & Clinics Market Size
      • 2.1.4.2 North America Ambulatory Surgery Diseases Market Size
      • 2.1.4.3 North America Others (Research Institutes Market Size
      • 2.1.4.4 North America etc.) Market Size
  • 2.2 United States Market Size 2021 - 2033
    • 2.2.1 United States Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 2.2.2 United States Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 2.2.3 United States Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 2.3 Canada Market Size 2021 - 2033
    • 2.3.1 Canada Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 2.3.2 Canada Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 2.3.3 Canada Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 2.4 Mexico Market Size 2021 - 2033
    • 2.4.1 Mexico Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 2.4.2 Mexico Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 2.4.3 Mexico Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.1 Europe Drug Repurposing Market Size 2021 - 2033
    • 3.1.1 Europe Drug Repurposing Market Size By Country 2021 - 2033
    • 3.1.2 Europe Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
      • 3.1.2.1 Europe Disease-centric approach Market Size
      • 3.1.2.2 Europe Target-centric approach Market Size
      • 3.1.2.3 Europe Drug-centric approach Market Size
    • 3.1.3 Europe Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
      • 3.1.3.1 Europe Oncology Market Size
      • 3.1.3.2 Europe CNS Diseases Market Size
      • 3.1.3.3 Europe Neurodegenerative Diseases Market Size
      • 3.1.3.4 Europe Others (Rare Disorders Market Size
      • 3.1.3.5 Europe etc.) Market Size
    • 3.1.4 Europe Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
      • 3.1.4.1 Europe Hospitals & Clinics Market Size
      • 3.1.4.2 Europe Ambulatory Surgery Diseases Market Size
      • 3.1.4.3 Europe Others (Research Institutes Market Size
      • 3.1.4.4 Europe etc.) Market Size
  • 3.2 United Kingdom Market Size 2021 - 2033
    • 3.2.1 United Kingdom Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.2.2 United Kingdom Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.2.3 United Kingdom Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.3 France Market Size 2021 - 2033
    • 3.3.1 France Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.3.2 France Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.3.3 France Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.4 Germany Market Size 2021 - 2033
    • 3.4.1 Germany Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.4.2 Germany Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.4.3 Germany Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.5 Italy Market Size 2021 - 2033
    • 3.5.1 Italy Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.5.2 Italy Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.5.3 Italy Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.6 Russia Market Size 2021 - 2033
    • 3.6.1 Russia Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.6.2 Russia Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.6.3 Russia Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.7 Spain Market Size 2021 - 2033
    • 3.7.1 Spain Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.7.2 Spain Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.7.3 Spain Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.8 Sweden Market Size 2021 - 2033
    • 3.8.1 Sweden Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.8.2 Sweden Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.8.3 Sweden Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.9 Denmark Market Size 2021 - 2033
    • 3.9.1 Denmark Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.9.2 Denmark Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.9.3 Denmark Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.10 Switzerland Market Size 2021 - 2033
    • 3.10.1 Switzerland Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.10.2 Switzerland Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.10.3 Switzerland Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.11 Luxembourg Market Size 2021 - 2033
    • 3.11.1 Luxembourg Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.11.2 Luxembourg Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.11.3 Luxembourg Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 3.12 Rest of Europe Market Size 2021 - 2033
    • 3.12.1 Rest of Europe Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 3.12.2 Rest of Europe Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 3.12.3 Rest of Europe Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.1 Asia Pacific Drug Repurposing Market Size 2021 - 2033
    • 4.1.1 Asia Pacific Drug Repurposing Market Size By Country 2021 - 2033
    • 4.1.2 Asia Pacific Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
      • 4.1.2.1 Asia Pacific Disease-centric approach Market Size
      • 4.1.2.2 Asia Pacific Target-centric approach Market Size
      • 4.1.2.3 Asia Pacific Drug-centric approach Market Size
    • 4.1.3 Asia Pacific Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
      • 4.1.3.1 Asia Pacific Oncology Market Size
      • 4.1.3.2 Asia Pacific CNS Diseases Market Size
      • 4.1.3.3 Asia Pacific Neurodegenerative Diseases Market Size
      • 4.1.3.4 Asia Pacific Others (Rare Disorders Market Size
      • 4.1.3.5 Asia Pacific etc.) Market Size
    • 4.1.4 Asia Pacific Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
      • 4.1.4.1 Asia Pacific Hospitals & Clinics Market Size
      • 4.1.4.2 Asia Pacific Ambulatory Surgery Diseases Market Size
      • 4.1.4.3 Asia Pacific Others (Research Institutes Market Size
      • 4.1.4.4 Asia Pacific etc.) Market Size
  • 4.2 China Drug Repurposing Market Size 2021 - 2033
    • 4.2.1 China Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.2.2 China Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.2.3 China Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.3 Japan Drug Repurposing Market Size 2021 - 2033
    • 4.3.1 Japan Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.3.2 Japan Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.3.3 Japan Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.4 South Korea Drug Repurposing Market Size 2021 - 2033
    • 4.4.1 South Korea Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.4.2 South Korea Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.4.3 South Korea Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.5 India Drug Repurposing Market Size 2021 - 2033
    • 4.5.1 India Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.5.2 India Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.5.3 India Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.6 Australia Drug Repurposing Market Size 2021 - 2033
    • 4.6.1 Australia Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.6.2 Australia Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.6.3 Australia Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.7 Singapore Drug Repurposing Market Size 2021 - 2033
    • 4.7.1 Singapore Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.7.2 Singapore Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.7.3 Singapore Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.8 Taiwan Drug Repurposing Market Size 2021 - 2033
    • 4.8.1 Taiwan Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.8.2 Taiwan Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.8.3 Taiwan Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.9 South East Asia Drug Repurposing Market Size 2021 - 2033
    • 4.9.1 South East Asia Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.9.2 South East Asia Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.9.3 South East Asia Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 4.10 Rest of APAC Drug Repurposing Market Size 2021 - 2033
    • 4.10.1 Rest of APAC Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 4.10.2 Rest of APAC Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 4.10.3 Rest of APAC Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 5.1 South America Drug Repurposing Market Size 2021 - 2033
    • 5.1.1 South America Drug Repurposing Market Size By Country 2021 - 2033
    • 5.1.2 South America Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
      • 5.1.2.1 South America Disease-centric approach Market Size
      • 5.1.2.2 South America Target-centric approach Market Size
      • 5.1.2.3 South America Drug-centric approach Market Size
    • 5.1.3 South America Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
      • 5.1.3.1 South America Oncology Market Size
      • 5.1.3.2 South America CNS Diseases Market Size
      • 5.1.3.3 South America Neurodegenerative Diseases Market Size
      • 5.1.3.4 South America Others (Rare Disorders Market Size
      • 5.1.3.5 South America etc.) Market Size
    • 5.1.4 South America Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
      • 5.1.4.1 South America Hospitals & Clinics Market Size
      • 5.1.4.2 South America Ambulatory Surgery Diseases Market Size
      • 5.1.4.3 South America Others (Research Institutes Market Size
      • 5.1.4.4 South America etc.) Market Size
  • 5.2 Brazil Drug Repurposing Market Size 2021 - 2033
    • 5.2.1 Brazil Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 5.2.2 Brazil Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 5.2.3 Brazil Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 5.3 Argentina Drug Repurposing Market Size 2021 - 2033
    • 5.3.1 Argentina Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 5.3.2 Argentina Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 5.3.3 Argentina Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 5.4 Colombia Drug Repurposing Market Size 2021 - 2033
    • 5.4.1 Colombia Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 5.4.2 Colombia Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 5.4.3 Colombia Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 5.5 Peru Drug Repurposing Market Size 2021 - 2033
    • 5.5.1 Peru Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 5.5.2 Peru Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 5.5.3 Peru Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 5.6 Chile Drug Repurposing Market Size 2021 - 2033
    • 5.6.1 Chile Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 5.6.2 Chile Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 5.6.3 Chile Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 5.7 Rest of South America Drug Repurposing Market Size 2021 - 2033
    • 5.7.1 Rest of South America Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 5.7.2 Rest of South America Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 5.7.3 Rest of South America Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 6.1 Middle East Drug Repurposing Market Size 2021 - 2033
    • 6.1.1 Middle East Drug Repurposing Market Size By Country 2021 - 2033
    • 6.1.2 Middle East Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
      • 6.1.2.1 Middle East Disease-centric approach Market Size
      • 6.1.2.2 Middle East Target-centric approach Market Size
      • 6.1.2.3 Middle East Drug-centric approach Market Size
    • 6.1.3 Middle East Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
      • 6.1.3.1 Middle East Oncology Market Size
      • 6.1.3.2 Middle East CNS Diseases Market Size
      • 6.1.3.3 Middle East Neurodegenerative Diseases Market Size
      • 6.1.3.4 Middle East Others (Rare Disorders Market Size
      • 6.1.3.5 Middle East etc.) Market Size
    • 6.1.4 Middle East Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
      • 6.1.4.1 Middle East Hospitals & Clinics Market Size
      • 6.1.4.2 Middle East Ambulatory Surgery Diseases Market Size
      • 6.1.4.3 Middle East Others (Research Institutes Market Size
      • 6.1.4.4 Middle East etc.) Market Size
  • 6.2 Saudi Arabia Drug Repurposing Market Size 2021 - 2033
    • 6.2.1 Saudi Arabia Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 6.2.2 Saudi Arabia Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 6.2.3 Saudi Arabia Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 6.3 Turkey Drug Repurposing Market Size 2021 - 2033
    • 6.3.1 Turkey Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 6.3.2 Turkey Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 6.3.3 Turkey Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 6.4 UAE Drug Repurposing Market Size 2021 - 2033
    • 6.4.1 UAE Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 6.4.2 UAE Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 6.4.3 UAE Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 6.5 Egypt Drug Repurposing Market Size 2021 - 2033
    • 6.5.1 Egypt Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 6.5.2 Egypt Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 6.5.3 Egypt Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 6.6 Qatar Drug Repurposing Market Size 2021 - 2033
    • 6.6.1 Qatar Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 6.6.2 Qatar Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 6.6.3 Qatar Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 6.7 Rest of Middle East Drug Repurposing Market Size 2021 - 2033
    • 6.7.1 Rest of Middle East Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 6.7.2 Rest of Middle East Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 6.7.3 Rest of Middle East Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 7.1 Africa Drug Repurposing Market Size 2021 - 2033
    • 7.1.1 Africa Drug Repurposing Market Size By Country 2021 - 2033
    • 7.1.2 Africa Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
      • 7.1.2.1 Africa Disease-centric approach Market Size
      • 7.1.2.2 Africa Target-centric approach Market Size
      • 7.1.2.3 Africa Drug-centric approach Market Size
    • 7.1.3 Africa Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
      • 7.1.3.1 Africa Oncology Market Size
      • 7.1.3.2 Africa CNS Diseases Market Size
      • 7.1.3.3 Africa Neurodegenerative Diseases Market Size
      • 7.1.3.4 Africa Others (Rare Disorders Market Size
      • 7.1.3.5 Africa etc.) Market Size
    • 7.1.4 Africa Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
      • 7.1.4.1 Africa Hospitals & Clinics Market Size
      • 7.1.4.2 Africa Ambulatory Surgery Diseases Market Size
      • 7.1.4.3 Africa Others (Research Institutes Market Size
      • 7.1.4.4 Africa etc.) Market Size
  • 7.2 Nigeria Drug Repurposing Market Size 2021 - 2033
    • 7.2.1 Nigeria Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 7.2.2 Nigeria Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 7.2.3 Nigeria Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 7.3 South Africa Drug Repurposing Market Size 2021 - 2033
    • 7.3.1 South Africa Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 7.3.2 South Africa Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 7.3.3 South Africa Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 7.4 Rest of Africa Drug Repurposing Market Size 2021 - 2033
    • 7.4.1 Rest of Africa Drug Repurposing Market Size by By Approach Type Outlook: 2021 - 2033
    • 7.4.2 Rest of Africa Drug Repurposing Market Size by By Disease Indication Outlook: 2021 - 2033
    • 7.4.3 Rest of Africa Drug Repurposing Market Size by By End-user Outlook: 2021 - 2033
  • 8.1 Top Competitors Analysis
    • 8.1.1 Top Players Ranking 2024

    • (Subject to Data Availability (Private Players))

      8.1.2 Global Drug Repurposing Market Revenue and Share by Key Players
    • 8.1.3 Industry Mergers and Acquisition Analysis
    • 8.1.4 New Product Launch Analysis
  • 8.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.1 Algernon Pharmaceuticals
      • 8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.1.2 Business Overview
      • 8.2.1.3 Financials (Subject to data availability)
      • 8.2.1.4 Product Types Specification
      • 8.2.1.5 Business Strategy
      • 8.2.1.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.2 Biovista Inc.
      • 8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.2.2 Business Overview
      • 8.2.2.3 Financials (Subject to data availability)
      • 8.2.2.4 Product Types Specification
      • 8.2.2.5 Business Strategy
      • 8.2.2.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.3 Celentyx Ltd.
      • 8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.3.2 Business Overview
      • 8.2.3.3 Financials (Subject to data availability)
      • 8.2.3.4 Product Types Specification
      • 8.2.3.5 Business Strategy
      • 8.2.3.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.4 ChemBio Discovery Inc.
      • 8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.4.2 Business Overview
      • 8.2.4.3 Financials (Subject to data availability)
      • 8.2.4.4 Product Types Specification
      • 8.2.4.5 Business Strategy
      • 8.2.4.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.5 Chord Therapeutics SA
      • 8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.5.2 Business Overview
      • 8.2.5.3 Financials (Subject to data availability)
      • 8.2.5.4 Product Types Specification
      • 8.2.5.5 Business Strategy
      • 8.2.5.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.6 Excelra
      • 8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.6.2 Business Overview
      • 8.2.6.3 Financials (Subject to data availability)
      • 8.2.6.4 Product Types Specification
      • 8.2.6.5 Business Strategy
      • 8.2.6.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.7 Fios Genomics Ltd.
      • 8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.7.2 Business Overview
      • 8.2.7.3 Financials (Subject to data availability)
      • 8.2.7.4 Product Types Specification
      • 8.2.7.5 Business Strategy
      • 8.2.7.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.8 Lantern Pharma Inc.
      • 8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.8.2 Business Overview
      • 8.2.8.3 Financials (Subject to data availability)
      • 8.2.8.4 Product Types Specification
      • 8.2.8.5 Business Strategy
      • 8.2.8.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.9 Novartis AG
      • 8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.9.2 Business Overview
      • 8.2.9.3 Financials (Subject to data availability)
      • 8.2.9.4 Product Types Specification
      • 8.2.9.5 Business Strategy
      • 8.2.9.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.10 Paradigm Biopharmaceuticals Limited
      • 8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.10.2 Business Overview
      • 8.2.10.3 Financials (Subject to data availability)
      • 8.2.10.4 Product Types Specification
      • 8.2.10.5 Business Strategy
      • 8.2.10.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.11 Predictive Oncology
      • 8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.11.2 Business Overview
      • 8.2.11.3 Financials (Subject to data availability)
      • 8.2.11.4 Product Types Specification
      • 8.2.11.5 Business Strategy
      • 8.2.11.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.12 Segue Therapeutics
      • 8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.12.2 Business Overview
      • 8.2.12.3 Financials (Subject to data availability)
      • 8.2.12.4 Product Types Specification
      • 8.2.12.5 Business Strategy
      • 8.2.12.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.13 LLC
      • 8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.13.2 Business Overview
      • 8.2.13.3 Financials (Subject to data availability)
      • 8.2.13.4 Product Types Specification
      • 8.2.13.5 Business Strategy
      • 8.2.13.6 S.W.O.TAnalysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.14 Teva Pharmaceutical Industries Ltd.
      • 8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.14.2 Business Overview
      • 8.2.14.3 Financials (Subject to data availability)
      • 8.2.14.4 Product Types Specification
      • 8.2.14.5 Business Strategy
      • 8.2.14.6 S.W.O.TAnalysis
  • 9.1 Impact of Trump's Tariff War on Drug Repurposing Market Data
    • 9.1.1 Policy Shifts That Influence the Drug Repurposing Market
    • 9.1.2 Tariff and their Long-Term Impact on the Drug Repurposing Market
    • 9.1.3 Trade Wars and Supply Chain Changes in the Drug Repurposing Market
    • 9.1.4 Regional and Geopolitical implications in the Drug Repurposing Market
    • 9.1.5 Tax Reforms and Business Expansion in the Drug Repurposing Market
    • 9.1.6 Investor Sentiment in Key Segments of the Drug Repurposing Market
    • 9.1.7 Environmental Rollbacks and ESG Implications in the Drug Repurposing Market
    • 9.1.8 Consumer Behavior and Brand Perception in the Politicized in Drug Repurposing Market
    • 9.1.9 Strategic takeaways for future administration in Drug Repurposing Market
  • 9.2 Market Drivers
  • 9.3 Market Restraints
  • 9.4 Market Trends
  • 9.5 Market Opportunity
  • 9.6 Technological Road Map (Subject to Data Availability)
  • 9.7 Product Life Cycle (Subject to Data Availability)
  • 9.8 Consumer Preference Analysis
  • 9.9 Market Attractiveness Analysis
  • 9.10 PESTEL Analysis
    • 9.10.1 Political Factors
    • 9.10.2 Economic Factors
    • 9.10.3 Social Factors
    • 9.10.4 Technological Factors
    • 9.10.5 Legal Factors
    • 9.10.6 Environmental Factors
  • 9.11 Industrial Chain Analysis (Subject to Data Availability)
    • 9.11.1 Industry Chain Analysis
    • 9.11.2 Manufacturing Cost Analysis
    • 9.11.3 Supply Side Analysis
      • 9.11.3.1 Raw Material Analysis
      • 9.11.3.2 Raw Material Procurement Analysis
      • 9.11.3.3 Raw Material Price Trend Analysis
  • 9.12 Porter’s Five Forces Analysis
    • 9.12.1 Bargaining Power of Suppliers
    • 9.12.2 Bargaining Power of Buyers
    • 9.12.3 Threat of New Entrants
    • 9.12.4 Threat of Substitutes
    • 9.12.5 Degree of Competition
  • 9.13 Patent Analysis (Subject to Data Availability)
  • 9.14 ESG Analysis
  • 10.1 Disease-centric approach
    • 10.1.1 Global Drug Repurposing Revenue Market Size and Share by Disease-centric approach 2021 - 2033
  • 10.2 Target-centric approach
    • 10.2.1 Global Drug Repurposing Revenue Market Size and Share by Target-centric approach 2021 - 2033
  • 10.3 Drug-centric approach
    • 10.3.1 Global Drug Repurposing Revenue Market Size and Share by Drug-centric approach 2021 - 2033
  • 11.1 Oncology
    • 11.1.1 Global Drug Repurposing Revenue Market Size and Share by Oncology 2021 - 2033
  • 11.2 CNS Diseases
    • 11.2.1 Global Drug Repurposing Revenue Market Size and Share by CNS Diseases 2021 - 2033
  • 11.3 Neurodegenerative Diseases
    • 11.3.1 Global Drug Repurposing Revenue Market Size and Share by Neurodegenerative Diseases 2021 - 2033
  • 11.4 Others (Rare Disorders
    • 11.4.1 Global Drug Repurposing Revenue Market Size and Share by Others (Rare Disorders 2021 - 2033
  • 11.5 etc.)
    • 11.5.1 Global Drug Repurposing Revenue Market Size and Share by etc.) 2021 - 2033
  • 12.1 Hospitals & Clinics
    • 12.1.1 Global Drug Repurposing Revenue Market Size and Share by Hospitals & Clinics 2021 - 2033
  • 12.2 Ambulatory Surgery Diseases
    • 12.2.1 Global Drug Repurposing Revenue Market Size and Share by Ambulatory Surgery Diseases 2021 - 2033
  • 12.3 Others (Research Institutes
    • 12.3.1 Global Drug Repurposing Revenue Market Size and Share by Others (Research Institutes 2021 - 2033
  • 12.4 etc.)
    • 12.4.1 Global Drug Repurposing Revenue Market Size and Share by etc.) 2021 - 2033
  • 13.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    13.2 Analyst Point of View
  • 13.3 Assumptions and Acronyms
  • 14.1 Primary Data Collection
    • 14.1.1 Steps for Primary Data Collection
      • 14.1.1.1 Identification of KOL
    • 14.1.2 Backward Integration
    • 14.1.3 Forward Integration
    • 14.1.4 How Primary Research Help Us
    • 14.1.5 Modes of Primary Research
  • 14.2 Secondary Research
    • 14.2.1 How Secondary Research Help Us
    • 14.2.2 Sources of Secondary Research
  • 14.3 Data Validation
    • 14.3.1 Data Triangulation
    • 14.3.2 Top Down & Bottom Up Approach
    • 14.3.3 Cross check KOL Responses with Secondary Data
  • 14.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.

2021

2025

2033

2021

2025

2033

Qualitative Analysis
Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc. Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.

Research Methodology Implemented by Manjiri Kanhere and Team

  • 1 Data Gathering
    • 1.1 Primary Research
      • 1.1.1 Steps for Primary Data Collection
        • 1.1.1.1 Identification of KOL
        • 1.1.1.2 Backward Integration
        • 1.1.1.3 Forward Integration
        • 1.1.1.4 How Primary Research Help Us
        • 1.1.1.5 Modes of Primary Research
    • 1.2 Secondary Research
      • 1.2.1 How Secondary Research Help Us
      • 1.2.2 Sources of Secondary Research
  • 2 Data Validation
    • 2.1 Cross check KOL Responses with Secondary Data
    • 2.2 Top Down & Bottom Up Approach
    • 2.3 Data Triangulation
  • 3 Data Representation
Preview Full Research Methodology

Key Questions Answered By Drug Repurposing Market Report 2025

Why Disease-centric approach have a significant impact on Drug Repurposing market?
What are the key factors affecting the Disease-centric approach and Target-centric approach of Drug Repurposing Market?
What is the CAGR/Growth Rate of Oncology during the forecast period?
By type, which segment accounted for largest share of the global Drug Repurposing Market?
Which region is expected to dominate the global Drug Repurposing Market within the forecast period?

We not only deliver the published report but only provide customized data on request to make your customized report edition (Exclusively Delivered and not shared on the website/Other Clients). The following additional data and delivery depend on Data Availability, Client's Data Request, Additional Charges Applied, etc.

Customize the Report Edition (Is applicable, On Request, Subject to Data Available, At an Additional Cost)
Segmentation Level Customization
  • Additional Segments and Sub Segment
  • Cross-split Segments of Drug Repurposing
  • Additional Countries Granular data
Global level Data Customization
  • Sales Volume
  • Production
  • Production Capacity
  • Pricing Analysis of Product
  • Company Market Share
Region level Data Customization
  • Sales Volume
  • Production
  • Production Capacity
  • Pricing Analysis of Product
  • Company Market Share
  • Customize the Region according to your data needs, eg. AMEA, BRIC, DACH, EMEA, MENA, Nordics, PIIGS, VISTA, and more regions or countries Combination can deliver a segregated market overview.
Country level Data Customization
  • Sales Volume
  • Production
  • Production Capacity
  • Segment Analysis on Country level is also available (On request)
  • Pricing Analysis of Product
  • Company Market Share
Company Level
  • Company Market Share on Regional Level/ Country Level
  • Company Sales Volume
  • Company Production Volume
  • Company Production Capacity
  • Company Specific Distributors
  • Manufacturing Process by different manufacturers
  • Global/ Regional/ Country level Major Distributors
  • Additional Competitors Analysis of your choice
  • Tier 1 tier 2 tier 3 start ups....
  • Manufacturers Market Concentration Ratio
  • Industry benchmarking
  • List of 2nd tier, 3rd tier and new players (data available). Please Note: Not all players are disclosed | Listed In No particular Order due to Data Confidentiality
Additional Data Analysis
  • Surveys/polls
  • Value Chain Analysis
  • Raw Material Analysis
  • Price Trend Analysis
  • Supplier/Distributor List
  • Market Economic
  • Supply Demand Gap Analysis
  • Customer Sentiment Analysis
  • Stock Price Prediction Analysis
  • Stock Performance Correlation Analysis
  • Patent Analysis
  • Technology Development Analysis
  • Merger and Acquistion Consulting
  • Top Winning Strategies / Strategic Benchmarkeing
  • Heat Map Analysis
  • ESG Analysis
  • Product life cycle
  • Customer buying behavior and decision-making process
  • Marketing Mix Analysis
  • Product Launch Strategy Building
Additional Qualitative Data
  • Pipeline Products
  • Market Trends
  • Industry Events and Developments
  • Sales Key Indicators
  • Risk Analysis
  • Regulatory Landscape
  • Customer Sentiment Analysis
  • R&D landscape
  • Market Entry / Exit Consulting
  • Identifying New Application/End Use
Additional Quantitative Data
  • Import Data
  • Export Data
  • Quarterly Revenue (Q1,Q2,Q3,Q4)
  • Forecast Period Extension: 2025 to 2033
  • Historical Period Data Available: 2021 to 2024
  • IPO prospectus
Service Level Customization
  • Quarterly Report Updates (Q1,Q2,Q3,Q4)
  • Annual Report Updates (Subscribe 1/2/3/4/...Years)
  • Exclusive Report Delivery (NDA)
  • Dedicated Research Analyst Support (Email, Calls, Interview)
  • Data Support (Unlimited Time Period)
  • Drug Repurposing Database Subscription (Full Access)
Report Format Alteration
  • Quarterly Revenue (Q1,Q2,Q3,Q4)
  • Revenue in USD ($)/Euro (€)/Pound (£)/Yen (¥)/etc
  • Translation Rights and Multi Language Report Editions
  • Average FOB Price/Average Selling Price

Reviews

Average Rating: 0

+ =
  (I'm not a robot)

NEED ASSISTANCE?

WRITE US

CALL US

BOOK APPOINTMENT

WRITE AN EMAIL

info@cognitivemarketresearch.com

sales@cognitivemarketresearch.com

admin@cognitivemarketresearch.com

CALL US

USA: (+1) 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Navigation
Share
  • Twitter